RxDoctor Payments Data

Elizabeth Pullman, PA

Physician Assistant · Abilene, TXNPI 1932808714

Payments from drug & device makers

$556in general payments, 2019–2025

Across 25 payments — averaging $22.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sumitomo Pharma America, Inc.$160
  • AbbVie$77
  • Mayne Pharma Commercial LLC$72
  • Amgen$63
  • Astellas Pharma US Inc$57
  • Biogen$42
  • plus $87 from 4 others

What the payments were for

  • Food & beverage$556100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$556 in reported general payments places this provider in the 55th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$2,838
Medicare patients
19
Services billed
46

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol32$1,331
Raloxifene Hcl12$610
Alendronate Sodium16$90

Paid to pharmacies, not to this prescriber.

Other physician assistant in Abilene

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →